Despite well conducted treatment, schizophrenic patients often remain symptomatic. Although multiple studies studied resistant patients, no data are available on partial responders (PR). The purpose of this study is to compare clinical, quality of life (QoL), cost of PR versus non symptomatic patients (full responders=FR), and to assess the evolution of PR.